Camden Capital, LLC Bristol Myers Squibb CO Transaction History

Camden Capital, LLC

$916 Million
Q1 2025

A detailed history of Camden Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Camden Capital, LLC holds 119,281 shares of BMY stock, worth $5.61 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

119,281

Previous 134,632 11.4%

Holding current value

$5.61 Million

Previous $7.61 Million 4.47%

% of portfolio

0.79%

Previous 0.86%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$53.9 - $63.11 $827,418 - $968,801	-15,351 Reduced 11.4%	119,281 $7.27 Million
Q4 2024 Jan 29, 2025	SELL	$51.92 - $59.94 $816,857 - $943,036	-15,733 Reduced 10.46%	134,632 $7.61 Million
Q3 2024 Nov 12, 2024	BUY	$39.66 - $51.75 $4.07 Million - $5.31 Million	102,590 Added 214.74%	150,365 $7.78 Million
Q2 2024 Aug 06, 2024	BUY	$40.25 - $52.99 $194,850 - $256,524	4,841 Added 11.28%	47,775 $1.98 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $105,795 - $119,952	2,205 Added 5.41%	42,934 $2.33 Million
Q4 2023 Feb 05, 2024	BUY	$48.48 - $57.85 $708,098 - $844,957	14,606 Added 55.91%	40,729 $2.09 Million
Q3 2023 Nov 03, 2023	BUY	$57.89 - $64.73 $93,550 - $104,603	1,616 Added 6.59%	26,123 $1.52 Million
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $701,765 - $779,201	-11,015 Reduced 31.01%	24,507 $1.57 Million
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $5,782 - $6,558	-88 Reduced 0.25%	35,522 $2.46 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $300,695 - $356,066	-4,391 Reduced 10.98%	35,610 $2.56 Million
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $538 - $318,040	4,139 Added 11.54%	40,001 $2.84 Million
Q2 2022 Aug 03, 2022	SELL	$72.62 - $79.98 $288,737 - $318,000	-3,976 Reduced 9.98%	35,862 $2.78 Million
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $1.21 Million - $1.45 Million	19,702 Added 97.84%	39,838 $2.92 Million
Q4 2021 Feb 28, 2022	SELL	$53.63 - $62.52 $29,550 - $34,448	-551 Reduced 2.66%	20,136 $1.26 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $39,418 - $45,952	735 Added 3.68%	20,687 $1.29 Million
Q3 2021 Nov 03, 2021	BUY	$59.17 - $69.31 $630,929 - $739,052	10,663 Added 114.79%	19,952 $1.18 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $77,820 - $84,746	-1,257 Reduced 11.92%	9,289 $621,000
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $7,595 - $8,542	-128 Reduced 1.2%	10,546 $666,000
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $115,018 - $130,336	1,992 Added 22.94%	10,674 $662,000
Q3 2020 Oct 30, 2020	BUY	$57.43 - $63.64 $191,012 - $211,666	3,326 Added 62.1%	8,682 $523,000
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $452,265 - $528,742	-8,250 Reduced 60.64%	5,356 $315,000
Q1 2020 Apr 13, 2020	SELL	$46.4 - $67.43 $3,851 - $5,596	-83 Reduced 0.61%	13,606 $758,000
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $673,635 - $878,696	13,689 New	13,689 $879,000

Others Institutions Holding BMY

# of Institutions

2,810

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $100B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Account

Camden Capital, LLC Bristol Myers Squibb CO Transaction History